AstraZeneca Pharma India Ltd Q1 FY2024 PAT climbs to Rs. 53.86 crore

AstraZeneca Pharma India Limited has reported Standalone financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 303.5705 crores during the period ended June 30, 2023 as compared to Rs. 282.7007 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 53.8607 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 17.2712 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 21.54 for the period ended June 30, 2023 as compared to Rs. 6.91 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 303.5705 crs	₹282.7007 crs	7.38%
Net Profit	₹53.8607 crs	₹17.2712 crs	211.85%
EPS	₹21.54	₹6.91	211.72%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 303.5705 crores during the period ended June 30, 2023 as compared to Rs.236.4462 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.53.8607 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.20.1526 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.21.54 for the period ended June 30, 2023 as compared to Rs.8.06 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 303.5705 crs	₹236.4462 crs	28.39%
Net Profit	₹53.8607 crs	₹20.1526 crs	167.26%
EPS	₹21.54	₹8.06	167.25%

Shares of AstraZeneca Pharma India Limited was last trading in BSE at Rs. 3909.70 as compared to the previous close of Rs. 3810.25. The total number of shares traded during the day was 839 in over 239 trades.

The stock hit an intraday high of Rs. 3938.95 and intraday low of 3807.70. The net turnover during the day was Rs. 3258400.00.

Source : Equity Bulls

Keywords

AstraZenecaPharmaIndia Q1FY24 ResultUpdate